Depression Drug Recall
Possible Mislabeling Prompts Recall of Depression Drug Citalopram
A product drug recall has been issued for Citalopram and Finasteride - two drugs manufactured by Greenstone, LLC, the FDA reported Monday. Incorrect labels may have been placed on the bottles by a third-party manufacturer, prompting the recall.
Citalopram, used to treat depression, may contain Finasteride, a drug for treating benign prostatic hyperplasia. Bottles labeled as Citalopram may contain Finasteride (used for treating benign prostatic hyperplasia). Patients who discontinue Citalopram by inadvertently taking the mislabeled product may experience discontinuation symptoms and/or worsening of depression.
Women who are, or may become pregnant, should not take or handle Finasteride due to possible side effect risks to a developing male fetus. The recall includes Citalopram 10mg Tablets (100-count bottle) and Finasteride 5mg Tablets (90-count bottle), both distributed in the U.S. market.
Drug manufacturer and pharmacy errors can be dangerous and, in some cases, they can have fatal consequences. Our firm has represented numerous clients who have been the victims of pharmacy errors. We have filed claims against virtually every major pharmacy in the country, and David W. Hodges and Galvin B. Kennedy are Board Certified in Personal Injury Trial Law by the Texas Board of Specialization.
If you or a loved one have suffered because of a product recall or defective drug, contact experienced product recall attorney s today at 713-523-0001, or toll-free at 877-342-2020. Our firm is located in Houston, TX, but we maintain a national practice. Read the latest updates on the DePuy hip implant recall on our blog .